Align Technology Net Common Equity Issued/Repurchased 2010-2024 | ALGN

Align Technology annual/quarterly net common equity issued/repurchased history and growth rate from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
  • Align Technology net common equity issued/repurchased for the quarter ending December 31, 2024 was $-0.328B, a 42.1% decline year-over-year.
  • Align Technology net common equity issued/repurchased for the twelve months ending December 31, 2024 was $-0.574B, a 58.66% decline year-over-year.
  • Align Technology annual net common equity issued/repurchased for 2024 was $-0.328B, a 42.1% decline from 2023.
  • Align Technology annual net common equity issued/repurchased for 2023 was $-0.566B, a 38.37% increase from 2022.
  • Align Technology annual net common equity issued/repurchased for 2022 was $-0.409B, a 17.02% increase from 2021.
Align Technology Annual Net Common Equity Issued/Repurchased
(Millions of US $)
2024 $-328
2023 $-566
2022 $-409
2021 $-349
2020 $20
2019 $-382
2018 $-283
2017 $-89
2016 $-82
2015 $-90
2014 $-80
2013 $-61
2012 $-5
2011 $18
2010 $12
2009 $8
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.648B $3.999B
Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Cardinal Health (CAH) United States $36.816B 19.28
Straumann Holding AG (SAUHY) Switzerland $21.909B 0.00
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 22.00
West Pharmaceutical Services (WST) United States $15.565B 32.63
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
CONMED (CNMD) United States $1.865B 13.96
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40